In addition, in non-carriers of GBA or LRRK2-G2019S mutations PD patients, GM3 species (d18:1/24:1 and d18:1/26:0) were found elevated in comparation with controls, correlated with high levels of GlcCer species in plasma [218]. This evidence concerns the gene LRRK2 and Parkinson disease.